WallStreetZenWallStreetZen

How to Buy Prelude Therapeutics Stock

Prelude Therapeutics Inc

Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients.

Prelude Therapeutics stock last closed at $3.70, down 3.39% from the previous day, and has decreased 41.92% in one year. It has underperformed other stocks in the Biotechnology industry by 0.23 percentage points. Prelude Therapeutics stock is currently +122.89% from its 52-week low of $1.66, and -46.22% from its 52-week high of $6.88.

At the moment, there are 54.93M shares of PRLD outstanding. The market cap of PRLD is $203.24M. In the past 24 hours, 36,872 PRLD shares were traded.

How to Buy Prelude Therapeutics Stock

Not sure how to invest in Prelude Therapeutics stock? Here's how.
  1. Choose where to buy Prelude Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you figure out where to buy Prelude Therapeutics stock.
  2. Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Deposit funds into your investment account: Pick your payment method and add your information.
  4. Research Prelude Therapeutics stock: The Prelude Therapeutics ticker symbol is PRLD. Is Prelude Therapeutics stock a good investment? Should you buy shares of PRLD? How do PRLD's underlying business fundamentals look? Do top analysts think Prelude Therapeutics is a good buy? Why has PRLD's stock price moved recently? (Hint: Our stock research website can help you evaluate if PRLD is a good stock to buy).
  5. Make your PRLD purchase: Decide if you will purchase PRLD shares at the current market price or use a limit order to purchase PRLD shares at a particular price.
  6. Keep an eye on your PRLD investment: Create a watchlist to important notifications about your new investment in Prelude Therapeutics shares.

Step 1: Choose where to buy Prelude Therapeutics stock

You will need a brokerage account to access the NASDAQ market and buy PRLD shares.

A brokerage account allows you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

We believe that eToro is the best brokerage. eToro gives you:

  • Invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
  • Access to world markets: From Tech to Real Estate, New York to Hong Kong — you can fill your portfolio with stocks from the globe's top exchanges.
  • Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your share purchase by signing up for an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for a brokerage account

Now that you've selected your brokerage, it's time to fill out some personal details so you can invest in PRLD today.

How to Open a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal info to open a new trading account.
  1. Send your info by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your investment account

Now that you've created your account on apps for stock market, your next step is to transfer the money for your investment:

Check out the walkthrough below for more details depositing money into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Prelude Therapeutics stock

After you have decided on the best place to buy Prelude Therapeutics stock, it's very important to research their stock before you invest, so you actually understand the risk as well as the opportunity.

Prelude Therapeutics Numbers

PRLD Price
$3.70
1w %
-1.86%
1y %
-41.92%
5y %
N/A
P/E
-1.97x
P/B
0.96x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$125.55M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$203.24M
Next Earnings
Jun 14, 2024
Next Dividend
N/A

Prelude Therapeutics Due Diligence Checks

WallStreetZen was created to help everyday investors perform more in-depth fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on PRLD's stock page.

Is PRLD stock undervalued?

You can use a variety of different financial metrics, analyses, models, and charts to gauge PRLD's true value.

Using relative valuations ratios:

  • PRLD may be undervalued based on its P/B ratio of 0.96x, relative to Biotechnology industry P/B ratio of 6.06x

You can do more valuation research on PRLD's stock here.

A quick look at PRLD Financials

Positive Health Checks:

  • PRLD has a low debt to equity ratio of 0.17.
  • There are more short-term assets than short-term liabilities on the PRLD balance sheet.
  • PRLD has cash burn of 111712000. It has sufficient cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than long-term liabilities on the PRLD balance sheet.

Negative Health Checks:

  • PRLD has $205.97M in cash and short term investments. This is not sufficient to cover its annual cash burn of $111.71M.

Is Prelude Therapeutics stock a Buy, Hold, or Sell, according to Wall Street analysts?

Out of 3 Wall Street analysts who give forecasts on PRLD, the consensus analyst rating on Prelude Therapeutics is a Hold

Please keep in mind that analyst ratings are not recommendations, nor are they financial advice.

You can dig deeper into what analysts are saying on the Prelude Therapeutics stock forecast page.

Metrics for Advanced PRLD Traders

SMA10
3.87
SMA20
4.2
SMA50
4.41
SMA100
4.04
SMA200
3.6
MACD
-0.21
MACD Signal
-0.17
MACD Histogram
-0.03
RSI
39.74
Stochastic %K
27.68
Stochastic %D
23.26
StochRSI %K
62.88
StochRSI %D
49.27

Are PRLD executives and large shareholders buying or selling the stock?

In the past 12 months, insiders at PRLD have bought more shares than they have sold.

Jane Huang, President CMO of PRLD, was the latest PRLD insider to sell. They sold $15,864.78 worth of PRLD shares on Apr 4, 2024.

Dig into more about who owns PRLD stock here.

Does PRLD stock generate passive income?

No, Prelude Therapeutics doesn't provide an income stream by paying out dividends.

What others are saying about PRLD

One of the reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to see what other investors have to say.

Step 5: Make your PRLD purchase

You have two main order types:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are generally sufficient.
  • Limit order: A limit order lets you buy or sell a security at a specific price (or better).
    If you want to make sure you're buying or selling at an exact price, use a limit order.

Hit the Open button and eToro will execute your order.

If you want more assistance buying stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Keep an eye on your PRLD investment

Now that you own some PRLD stock, you'll want to keep up with your new investment.

Add PRLD to a watchlist to get alerted to the latest events about your PRLD stock.

PRLD Feed

How to Buy Stock in Prelude Therapeutics

To summarize, here are the 6 steps you need to take to buy Prelude Therapeutics stock right now:

  1. Choose where to buy Prelude Therapeutics stock
  2. Sign up for a brokerage account
  3. Deposit funds into your investment account
  4. Research Prelude Therapeutics stock
  5. Make your PRLD purchase
  6. Keep an eye on your PRLD investment

If you are looking for a brokerage, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to track your investment in Prelude Therapeutics, create a watchlist today.

NASDAQ: PRLD
$3.70-0.13 (-3.39%)
Updated May 7, 2024
Open eToro Account
NASDAQ: PRLD
$3.70-0.13 (-3.39%)
Updated May 7, 2024
Open eToro Account

FAQ

How much does it cost to buy one Prelude Therapeutics share?

As of May 7, 2024, it costs $3.70 to buy one share of Prelude Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.27 shares of PRLD.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Prelude Therapeutics stock?

According to 3 Wall Street analysts who monitor Prelude Therapeutics, their consensus recommendation is to hold Prelude Therapeutics stock.

What is the best way to buy Prelude Therapeutics stock?

One way to place an order for Prelude Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.